Author:
Stratman Scott,Fernandez Rafle,França Katlein
Publisher
Springer International Publishing
Reference49 articles.
1. Andrews, T. C., Reimold, S. C., Berlin, J. A., & Antman, E. M. (1991). Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials. Circulation, 84(5 Suppl), III236–III244.
2. Arnon, S. S., Schechter, R., Inglesby, T. V., et al. (2001). Botulinum toxin as a biological weapon: Medical and public health management. Journal of the American Medical Association, 285(8), 1059–1070.
3. Blitzer, A., Brin, M. F., & Stewart, C. F. (2015). Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): A 12-year experience in more than 900 patients. The Laryngoscope, 125(8), 1751–1757.
4. Borodic, G., Johnson, E., Goodnough, M., & Schantz, E. (1996). Botulinum toxin therapy, immunologic resistance, and problems with available materials. Neurology, 46(1), 26–29.
5. Brandt, F., O’Connell, C., Cazzaniga, A., & Waugh, J. M. (2010). Efficacy and safety evaluation of a novel botulinum toxin topical gel for the treatment of moderate to severe lateral canthal lines. Dermatologic Surgery, 36(Suppl 4), 2111–2118.